| |
|
|
|
VistaGen Therapeutics Inc.  
|
|
0.7594 -0.015 (-0.02%) |
06-17 15:59 |
|
Open: |
0.75 |
Pre close: |
0.7744 |
Target:
|
1.00 
|
|
High: |
0.8 |
Low: |
0.75 |
Resistance:
|
0.86
1.05
|
|
Volume: |
81,681 |
Market Cap: |
32M |
Support:
|
0.54
0.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.78
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.80 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.13 |
Stochastic Oscillator |
%K(14,3):
|
12.60 |
|
MA(250): |
1.40 |
%D(3): |
16.81 |
|
Average Volume(K) |
3-Month: |
40702
|
52-Week |
High:
|
2.44 |
|
10-Days: |
17059 |
Low: |
0.52 |
|
RSI |
RSI(14):
|
43.54 |
Change(%): |
-48.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.160 |
Return on Equity (ttm) |
-402.7 |
Shares Out. (M) |
41.12 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-221.1 |
Shares Float (M) |
40.81 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
15.70 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
18.760 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.57 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.55 |
P/CF |
-2.30 |
|
|
|
|
|
|
